수탁제조 업계의 M&A : 함의와 전망(2024년판)

This report is the fifth edition of our analysis of mergers and acquisitions in the pharmaceutical contract manufacturing industry. PharmSource is the most definitive, trustworthy source of strategic insight on this topic in the bio/pharmaceutical realm.

Scope

This 53-page report gives important, expert insight you won't find in any other source. 12 tables and 19 figures throughout the report illustrate major points and trends. This report is required reading for -

• CMOs: market trends, strategic planning, competitive intelligence, performance benchmarking
• Bio/Pharma: supplier performance benchmarking, market trends, competitive intelligence
• Private equity and stock analysts: target identification and analysis, portfolio company performance benchmarking

Reasons to Buy

• Overview of M&A in the Pharma CMO Industry
• Detailed view of CDMO performance by number of deals, based on GlobalData's Deals database
• Analysis of M&A and private equity investment by target's specific manufacturing services

Table of Contents

Table of Contents

• Executive Summary
• Players
• Technology Briefing
• Deal types.
• Trends
• Industry Analysis
• Objectives and methodology
• Overview of M&A activity 2023
• Target characteristics
• Acquirer characteristics
• Geography
• Top acquirers
• Biosynth acquires Celares and Pepceuticals
• IPCA Laboratories invests in Unichem
• Target segment close-ups
• Multi
• API-small molecule
• API-biologic
• Commercial dose manufacturing
• Deal advisors.
• Top financial advisors
• Top legal advisors
• Valuations
• Facility acquisitions
• What it means
• Drug shortages drive low-tech small molecule deals.
• Multi-service and injectable manufacturers targeted
• Catalent acquisition shakes up pharma and CMO landscape.
• Biologic acquisitions decreased in 2023 but strong interest remains, despite BIOSECURE Act complicating manufacturing agreements
• Private equity investments declined
• The outlook for M&A
• API - biologic targets
• API - cell and gene therapy targets
• Value Chain
• Companies

Appendix

• Methodology
• Bibliography
• Primary research - key opinion leaders
• Further reading
• About the Authors